Showing results (71-80 of 88) with videos related to
Sort By:
Pageof 9
Gynecologic Oncology|May 1, 1997
Analysis of Ki-ras, p53, and MDM2 genes in uterine leiomyomas and leiomyosarcomasK L Hall, M G Teneriello, R R Taylor, et al.British Journal of Cancer|March 7, 2013
BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group StudyJ L Lesnock, K M Darcy, C Tian, et al.Science (New York, N.Y.)|October 27, 1989
p53: a frequent target for genetic abnormalities in lung cancerT Takahashi, M M Nau, I Chiba, et al.Oncogene|September 24, 2013
Identification of LMX1B as a novel oncogene in human ovarian cancerL He, L Guo, V Vathipadiekal, et al.Journal of Cellular Biochemistry. Supplement|January 1, 1992
Candidate biomarkers for application as intermediate end points of lung carcinogenesisJ L Mulshine, R I Linnoila, A M Treston, et al.Molecular Pharmacology|January 13, 1998
Coordinate regulation of stress- and mitogen-activated protein kinases in the apoptotic actions of ceramide and sphingosineW D Jarvis, F A Fornari, K L Auer, et al.Journal of the National Cancer Institute. Monographs|January 1, 1992
Rational targets for the early detection of lung cancerJ L Mulshine, R I Linnoila, S M Jensen, et al.Journal of the National Cancer Institute|July 3, 1991
Occurrence of p53 gene abnormalities in gastric carcinoma tumors and cell linesJ H Kim, T Takahashi, I Chiba, et al.Oncogene|January 9, 2001
Lovastatin induces apoptosis in a primitive neuroectodermal tumor cell line in association with RB down-regulation and loss of the G1 checkpointJ S Kim, F Pirnia, Y H Choi, et al.Nature|March 7, 1996
Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosisM Verheij, R Bose, X H Lin, et al.Pageof 9